We just received data on a new analyst forecast for $IBM. Stifel gave a rating of 'Buy' for $IBM.
$IBM Analyst Ratings
Wall Street analysts have issued reports on $IBM in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 07/16/2025
- UBS issued a "Sell" rating on 07/09/2025
- Goldman Sachs issued a "Buy" rating on 07/02/2025
- Wedbush issued a "Outperform" rating on 06/20/2025
- B of A Securities issued a "Buy" rating on 06/18/2025
- RBC Capital issued a "Outperform" rating on 05/15/2025
- Oppenheimer issued a "Outperform" rating on 02/11/2025
To track analyst ratings and price targets for $IBM, check out Quiver Quantitative's $IBM forecast page.
$IBM Price Targets
Multiple analysts have issued price targets for $IBM recently. We have seen 12 analysts offer price targets for $IBM in the last 6 months, with a median target of $282.5.
Here are some recent targets:
- David Grossman from Stifel set a target price of $310.0 on 07/16/2025
- David Vogt from UBS set a target price of $195.0 on 07/09/2025
- James Schneider from Goldman Sachs set a target price of $310.0 on 07/02/2025
- Daniel Ives from Wedbush set a target price of $325.0 on 06/20/2025
- Wamsi Mohan from B of A Securities set a target price of $320.0 on 06/18/2025
- Matthew Swanson from RBC Capital set a target price of $285.0 on 05/15/2025
- Erik Woodring from Morgan Stanley set a target price of $233.0 on 04/24/2025
$IBM Congressional Stock Trading
Members of Congress have traded $IBM stock 10 times in the past 6 months. Of those trades, 9 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $IBM stock by members of Congress over the last 6 months:
- REPRESENTATIVE LLOYD DOGGETT has traded it 2 times. They made 2 purchases worth up to $30,000 on 06/10, 03/10 and 0 sales.
- REPRESENTATIVE JONATHAN L. JACKSON has traded it 2 times. They made 2 purchases worth up to $150,000 on 06/03, 05/14 and 0 sales.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
- REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 04/03.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 3 purchases worth up to $45,000 on 03/26, 03/11, 03/10 and 0 sales.
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 03/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$IBM Insider Trading Activity
$IBM insiders have traded $IBM stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $IBM stock by insiders over the last 6 months:
- ROBERT DAVID THOMAS (Senior Vice President) sold 26,543 shares for an estimated $6,715,639
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IBM Hedge Fund Activity
We have seen 1,488 institutional investors add shares of $IBM stock to their portfolio, and 1,381 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 7,568,066 shares (+57.5%) to their portfolio in Q1 2025, for an estimated $1,881,875,291
- GAMMA INVESTING LLC removed 4,380,126 shares (-99.6%) from their portfolio in Q2 2025, for an estimated $1,291,173,542
- GQG PARTNERS LLC added 4,182,647 shares (+inf%) to their portfolio in Q1 2025, for an estimated $1,040,057,003
- CAPITAL WORLD INVESTORS added 3,544,033 shares (+29.6%) to their portfolio in Q1 2025, for an estimated $881,259,245
- MORGAN STANLEY added 2,486,922 shares (+17.8%) to their portfolio in Q1 2025, for an estimated $618,398,024
- CASTLEKEEP INVESTMENT ADVISORS LLC removed 1,371,064 shares (-99.6%) from their portfolio in Q1 2025, for an estimated $340,928,774
- VANGUARD GROUP INC added 1,298,515 shares (+1.4%) to their portfolio in Q1 2025, for an estimated $322,888,739
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
